Induction chemotherapy added to chemoradiation improves PFS and OS in advanced cervical cancer - report from ESMO2023

from Medical Digest & Congress Report · host Medical Congress News

Professor Mary McCormack explains the results from the GCIG INTERLACE trial presented in a Presidential Symposium at the ESMO Congress 2023. Phase III trial findings reveal significant improvements in PFS and OS rates, although the population studied may not be wholly indicative of high-risk disease. Video: https://medicaldigest.org/scientific-contents/interview:induction-chemotherapy-added-chemoradiation-improves-pfs-and-os-advanced-cervical-cancer

Episode metadata supplied by the publisher feed · Published Nov 2, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Induction chemotherapy added to chemoradiation improves PFS and OS in advanced cervical cancer - report from ESMO2023

0:00 3:22

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 3 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on November 2, 2023.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!